dry mouth on semaglutide GLP-1 Medications and Mouth: Managing New Side Effects 🦷✨ Did you know that

Some patients with obesity and metabolic syndromethe population commonly prescribed tirzepatidemay have underlying inflammatory conditions that coincidentally become apparent during treatment

She said the treatment complemented her healthy lifestyle, easing joint pain, boosting energy, and simply helping things work better

What are the safety considerations for both platforms

Diabetol Metab Syndr (2014) 6(1):29

5-HT 4 receptor agonists Prucalopride, a selective 5-hydroxytryptamine 4 (5-HT 4 ) receptor agonist, was effective in improving symptoms in a cohort with predominantly idiopathic gastroparesis, but despite accelerating gastric emptying in a diabetes-specific group, did not improve symptoms [73]

doi: 10.2337/diacare.27.10.2444